These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34991507)

  • 1. Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania.
    Hogendoorn SKL; Lhopitallier L; Richard-Greenblatt M; Tenisch E; Mbarack Z; Samaka J; Mlaganile T; Mamin A; Genton B; Kaiser L; D'Acremont V; Kain KC; Boillat-Blanco N
    BMC Infect Dis; 2022 Jan; 22(1):39. PubMed ID: 34991507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Accuracy of Soluble Triggering Receptor Expressed on Myeloid Cells (sTREM-1)-based Algorithms in Febrile Adults Presenting to Tanzanian Outpatient Clinics.
    Richard-Greenblatt M; Boillat-Blanco N; Zhong K; Mbarack Z; Samaka J; Mlaganile T; Kazimoto T; D'acremont V; Kain KC
    Clin Infect Dis; 2020 Mar; 70(7):1304-1312. PubMed ID: 31102510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections.
    ten Oever J; Tromp M; Bleeker-Rovers CP; Joosten LA; Netea MG; Pickkers P; van de Veerdonk FL
    J Infect; 2012 Dec; 65(6):490-5. PubMed ID: 22898387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
    España PP; Capelastegui A; Bilbao A; Diez R; Izquierdo F; Lopez de Goicoetxea MJ; Gamazo J; Medel F; Salgado J; Gorostiaga I; Quintana JM;
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3397-405. PubMed ID: 23010902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
    Le Bel J; Hausfater P; Chenevier-Gobeaux C; Blanc FX; Benjoar M; Ficko C; Ray P; Choquet C; Duval X; Claessens YE;
    Crit Care; 2015 Oct; 19():366. PubMed ID: 26472401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.
    Mendelson F; Griesel R; Tiffin N; Rangaka M; Boulle A; Mendelson M; Maartens G
    BMC Infect Dis; 2018 Aug; 18(1):399. PubMed ID: 30107791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.
    Drozdov D; Dusemund F; Müller B; Albrich WC
    Antibiotics (Basel); 2013 Jan; 2(1):1-10. PubMed ID: 27029288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.
    Holm A; Pedersen SS; Nexoe J; Obel N; Nielsen LP; Koldkjaer O; Pedersen C
    Br J Gen Pract; 2007 Jul; 57(540):555-60. PubMed ID: 17727748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
    Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
    BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial.
    Branche AR; Walsh EE; Jadhav N; Karmally R; Baran A; Peterson DR; Falsey AR
    PLoS One; 2016; 11(4):e0152986. PubMed ID: 27043012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
    Albrich WC; Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Bachli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Gaillat J; Schuetz P; Regez K; Bossart R; Schild U; Mueller B;
    Arch Intern Med; 2012 May; 172(9):715-22. PubMed ID: 22782201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
    Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
    Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.
    Miedema KG; de Bont ES; Elferink RF; van Vliet MJ; Nijhuis CS; Kamps WA; Tissing WJ
    Support Care Cancer; 2011 Oct; 19(10):1593-600. PubMed ID: 20803037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
    PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.
    Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Baechli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Schuetz P; Gaillat J; Regez K; Bossart R; Schild U; Müller B; Albrich WC;
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):51-60. PubMed ID: 22886090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.